Physician profile
James Shepherd
NPI 1235335530
$10,392.22
in general payments reported to CMS, 2019-2025
22 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.12 · 2020: $165 · 2021: $134 · 2022: $6,621 · 2023: $745 · 2024: $2,355 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,263 · Travel and Lodging: $1,154 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,262.72 |
| Travel and Lodging | $1,153.69 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,720.33 | 2019-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Allergan, INC. | $253.37 | 2020-2022 | |
| Davol INC. | $196.63 | 2021-2024 | Phasix Mesh, Arista Ah Flexitip |
| Ethicon US, LLC | $187.76 | 2023-2025 | Echelon Circular, Echelon; Endopath, Ethicon |
| Baxter Healthcare | $172.41 | 2023-2025 | Perclot, Tisseel |
| Kerecis Limited | $139.66 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Karl Storz Endoscopy-America | $103.10 | 2023-2025 | Image 1 S, Na |
| W. L. Gore & Associates, INC. | $102.66 | 2024-2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Smith+Nephew, INC. | $89.81 | 2024-2025 | Collagenase Santyl, Renasys Touch, Pico 14 |
| Mimedx Group, INC. | $80.65 | 2024 | |
| Medtronic, INC. | $62.44 | 2022-2025 | Interstim, Venaseal |
| Convatec INC. | $50.67 | 2025 | |
| Myriad Genetic Laboratories, INC. | $35.83 | 2022-2023 | Myrisk |
| Organogenesis INC. | $34.65 | 2024 | |
| Cvrx, INC. | $30.43 | 2024 | Barostim Neo System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $22.23 | 2024 | Activ.A.C. |
| Bsn Medical INC | $20.70 | 2025 | |
| Philips North America LLC | $20.40 | 2025 | Igt Devices Undivided |
| Abbvie INC. | $20.04 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Acell, INC. | $19.99 | 2019 | |
| Boston Scientific Corporation | $15.97 | 2024 | Varithena Administration Pack |
| Mallinckrodt Hospital Products INC. | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.